Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Discover which cash back cards have no fees. Find your ideal card and enjoy rewards without extra costs.
28,185 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
William Raveis Real Estate signs a strategic partnership with Lance Vermeulen Real Estate to expand Berkshire County ...
DeFi is at a crossroads: grow or endure risk. Experts propose a defended capital metric to measure true resilience be...
A key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
Hackers gained access to GitHub’s internal repos through a compromised developer tool, prompting rapid credential rot...
Fidelity has alerted owners of 500-stock funds that the S&P 500 is dominated by a small group of mega-caps, raising q...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Microsoft cutting 4,800 jobs marks a bold pivot toward AI and cloud infrastructure. The move comes with a hefty capex...
Consensys says a third-party contractor linked to North Korea accessed MetaMask code for roughly a month before acces...
XRP faces a steep pullback even as investor chatter surges. Grayscale’s sentiment report brands XRP as the second-mos...
The Pentagon’s fight with Anthropic has become a landmark test of how the U.S. will regulate powerful AI. Markets and...